Delivery Order SPE2DP23D0002-SPE2DP23F2627
Award Date 3/7/23
Potential Completion Date 10/13/23
Potential Value $2.9M
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Summit, NJ 07901, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency's Medical Supply Chain to Seqirus USA Inc., a foreign-owned, for-profit biotechnology company, for the provision of influenza virus vaccines. The contract, valued at $12,072,680.00, has an ultimate completion date of October 13, 2023. Seqirus USA Inc. is a global leader in the development, manufacturing, and delivery of influenza vaccines to various federal government agencies. The company holds several...
- The U.S. Department of Defense's Medical Supply Chain awarded a $3,102,020.00 firm fixed-price delivery order contract to Seqirus USA Inc., a foreign-owned, for-profit biotechnology company, for the supply of influenza virus vaccines. The contract has an ultimate completion date of October 13, 2023. This delivery order is part of Seqirus's existing Indefinite Delivery Contracts (IDCs) with the Defense Logistics Agency and Centers for Disease Control and Prevention, which allow federal agencies...
- This is a $12,738,750.00 firm-fixed-price delivery order awarded by the Defense Logistics Agency's Medical Supply Chain to Seqirus USA Inc., a foreign-owned, for-profit biotechnology company that specializes in manufacturing influenza vaccines. The contract is for the delivery of influenza virus vaccines, with a period of performance ending on October 13, 2023. Seqirus USA Inc. is a global leader in influenza vaccine development, manufacturing, and delivery, and has been awarded numerous federal...
- This is a $4,588,128.50 firm-fixed-price delivery order contract awarded to Seqirus USA Inc., a foreign-owned, for-profit manufacturer of influenza vaccines, by the Defense Logistics Agency's Medical Supply Chain. The contract is for the delivery of influenza virus vaccines and does not have a set-aside designation. Seqirus USA Inc. is a significant federal contractor, holding several large Indefinite Delivery Contracts (IDCs) with agencies like the Department of Veterans Affairs and Centers for...
- This is a delivery order awarded by the Defense Logistics Agency's Medical Supply Chain unit to Seqirus USA Inc., a global biotechnology company that specializes in influenza vaccine development and delivery. The order, valued at $9,597,690.00, is for the supply of influenza virus vaccines. Seqirus USA Inc. has been awarded multiple federal contracts and task orders to provide influenza vaccines to various government healthcare programs and agencies, including the Department of Veterans Affairs,...
- The U.S. Department of Defense's Medical Supply Chain (Defense Logistics Agency) awarded a $204,000.00 firm-fixed-price delivery order contract to Seqirus USA Inc. to provide influenza virus vaccines. This contract, awarded on October 23, 2024, has an ultimate completion date of November 4, 2024. Seqirus USA Inc., a foreign-owned, for-profit manufacturer of goods, has been awarded multiple indefinite delivery contracts (IDCs) with the Department of Veterans Affairs, Defense Logistics Agency, and...
- This is a $10,091,030 Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency Troop Support Medical to Seqirus USA Inc. for the delivery of influenza virus vaccines. The contract has a period of performance through September 27, 2024. Seqirus is a global biotechnology company that specializes in the development and delivery of influenza vaccines. The company has been awarded numerous federal contracts and delivery orders to provide influenza vaccines to various...
- This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Medical Supply Chain to Seqirus USA Inc. for the delivery of influenza virus vaccines. The contract has a ceiling value of $259,000.00 and a period of performance ending on November 30, 2015. Seqirus USA Inc. is a global biotechnology company that specializes in the development, manufacturing, and delivery of influenza vaccines to various federal government agencies. This contract supports annual flu...
- This federal contract award, SPE2DP15D0004|0006, was issued by the Defense Logistics Agency (DLA) Medical Supply Chain to Seqirus USA Inc., a foreign-owned, for-profit manufacturer of influenza vaccines. The $142,200.00 firm-fixed-price delivery order is for the supply of influenza virus vaccines, with an ultimate completion date of November 30, 2015. The contract is not designated as a set-aside. Seqirus USA Inc. has been awarded numerous similar federal contracts to supply influenza vaccines...
- This is a firm-fixed-price delivery order awarded by the Federal Medical Center Rochester, a civilian agency, to Seqirus USA Inc. through its Seqirus USA, Inc. division. The contract is for the FY25 supply of Seqirus's high-dose influenza vaccine, with a ceiling value of $2,938.20 and a completion date of September 30, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Seqirus holds with the Department of Veterans Affairs (VA) National Acquisition Center,...